ABL Europe’s business development team have a technical background in all phases of development and manufacture of GMP viral vectors, working with biotech & Pharma companies located globally.
From the initial point of contact, a dedicated business development manager will be happy to respond and guide potential clients through all stages of the bidding process.
The commitment required by both parties through the complete outsourced selection process is considerable, where a mutual qualification of fit is determined step-by-step on a confidential and informed data driven basis.
Following the receipt of a formal request for proposal (RFP) from the product sponsor, ABL will perform a detailed technical, regulatory and business review of the client’s outsourced CMC requirements.
The initial qualification of fit and decision to proceed with the generation of a technical scope of work and business proposal, will be determined from the RFP and answers to any questions raised.
Typically, a formal business proposal can be provided by ABL within 3 – 4 weeks of the initial decision to proceed. ABL actively encourages open and direct feedback on all aspects of its proposals.